UCC Innovation unveils microbiome sequencing spinout SeqBiome

A new study helps to explain how nerve cells sense the microbes in the gut and how they coordinate their function with other tissues in the digestive tract.

Molecules that remodel the gut microbiota reverse narrowing of arteries in mice

Researchers have developed molecules that remodel the gut microbiota to a healthier state, reducing cholesterol levels and inhibiting atherosclerosis.

Christophe Lacroix: ‘Our challenge is to culture anaerobic bacteria’

PharmaBiome has developed unique technologies to access the entire range of intestinal bacteria. We met Christophe Lacroix, Founder of Pharmabiome.

DuPont inks deal with Rutgers to focus on microbiome links to cancer therapies

A new study helps to explain how nerve cells sense the microbes in the gut and how they coordinate their function with other tissues in the digestive tract.

Biofilm-coated bacteria could help to treat gastrointestinal infections

Researchers have developed an approach that uses bacterial biofilms to increase the ability of the gut microbiota to survive and reside in the gastrointestinal tract.

Live Biotherapeutic Products: A path to addressing the regulatory and technical challenges?

A new study helps to explain how nerve cells sense the microbes in the gut and how they coordinate their function with other tissues in the digestive tract.

Specific disease-modifying gut bacteria characterize Parkinson’s disease across countries

A japanese team identified bacterial populations that may determine intestinal pathology and influence the development of Parkinson's disease.

Gut microbes could regulate immune response against colon cancer

Researchers have found that the gut microbiota and the death of intestinal cells caused by chemotherapy can enhance the immune response of people with colon cancer.

ProDigest customized solutions in gut microbiome research

ProDigest recreates the gastrointestinal tract to assess the mechanism of action of components such as prebiotics, probiotics or drugs.

New approach shows how microbial communities in the gut alter drug safety and efficacy

Researchers have found that the community of bacteria in a person’s gut can alter how well they metabolize drugs.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.